BROOKS LABORATORIES LTD. - 533543 - Clarification On Non-Submission Of Statement Of Deviation(S) Or Variation(S) For The Quarter Ended December 31, 2022.
Clarification on Non-submission of Statement of Deviation(s) or Variation(s) for the quarter ended December 31, 2022. BROOKS LABORATORIES LTD. - 533543 - Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations, 2015
Certificate from Practicing Company Secretary Under Regulation 40(9) Of SEBI (LODR) Regulations, 2015 BROOKS LABORATORIES LTD. - 533543 - Non-Applicability Of Large Corporate Criteria
Non-Applicability Of Large Corporate Criteria BROOKS LABORATORIES LTD. - 533543 - Compliance Certificate Under Regulation 7(3) Of The SEBI (LODR) Regulations, 2015 For The Year Ended March 31, 2023
Compliance Certificate Under Regulation 7(3) Of The SEBI (LODR) Regulations, 2015 For The Year Ended March 31, 2023 BROOKS LABORATORIES LTD. - 533543 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under regulation 74(5) of SEBI (DP)Regulation 2018 BROOKS LABORATORIES LTD. - 533543 - Closure of Trading Window
Closure of Trading Window for March 31, 2023 BROOKS LABORATORIES LTD. - 533543 - Clarification On Price Movement
Clarification on price movement BROOKS LABORATORIES LTD. - 533543 - Clarification sought from Brooks Laboratories Ltd
The Exchange has sought clarification from Brooks Laboratories Ltd on March 20, 2023 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited. BROOKS LABORATORIES LTD. - 533543 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyBROOKS LABORATORIES LTD. 2CIN NO.L24232HP2002PLC000267 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.01 4Highest Credit Rating during the previous FY BB- 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CARE RATINGS LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: JAI VAIDYA Designation: COMPANY SECRETARY CUM COMPLIANCE OFFICER EmailId: [email protected] Name of the Chief Financial Officer: PRASHANT RATHI Designation: CHIEF FINANCIAL OFFICER EmailId: [email protected] Date: 04/03/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. BROOKS LABORATORIES LTD. - 533543 - Shareholders Approval For Rights Issue By Postal Ballot.
Shareholders Approval for Rights Issue by Postal Ballot.